Otros idiomas AbbVie Inc. Deutsche Boerse AG

Acciones

Mercado cerrado - Deutsche Boerse AG Otros sitios de cotización 14:56:04 01/07/2024			Varia. Cinco días.	Varia. 1 de enero.
159,5 ^EUR	+0,34 %		-0,68 %	+14,61 %

01/07	Merus nombra nuevo director médico	MT
01/07	AbbVie dice que Robert Michael asume el papel de consejero delegado	MT

Merus Names New Chief Medical Officer	01/07
AbbVie : le nouveau directeur général prend ses fonctions	01/07
AbbVie Says Robert Michael Assumes CEO Role	01/07
Blackrock : Boeing, Meta...les valeurs à suivre aujourd'hui à Wall Street	01/07
AbbVie : Robert A. Michael prend les commandes d’AbbVie	01/07
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer	01/07
AbbVie Announces Board Changes	01/07
AbbVie - Introducing Alle Payment Plans, Powered by Cherry	28/06
Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	28/06
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	28/06
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06
AbbVie Receives Positive CHMP Opinion for Epcoritamab for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06
Health Care Stocks Fall With Broad Market -- Health Care Roundup	27/06
Sector Update: Health Care Stocks Slipping Late Afternoon	27/06
Sector Update: Health Care Stocks Decline in Afternoon Trading	27/06
AbbVie : acquisition de Celsius pour 250 millions de dollars	27/06
AbbVie Buys Celsius Therapeutics for $250 Million	27/06
AbbVie Buys Celsius Therapeutics for $250 million	27/06
AbbVie Buys Celsius Therapeutics for $250 million	27/06
AbbVie Acquires Celsius Therapeutics in $250 Million Cash Deal	27/06

No hay resultados para esta búsqueda